Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.
Spathis AD, Asvos X, Ziavra D, Karampelas T, Topouzis S, Cournia Z, Qing X, Alexakos P, Smits LM, Dalla C, Rideout HJ, Schwamborn JC, Tamvakopoulos C, Fokas D, Vassilatis DK. Spathis AD, et al. Among authors: vassilatis dk. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3999-4004. doi: 10.1073/pnas.1616874114. Epub 2017 Mar 27. Proc Natl Acad Sci U S A. 2017. PMID: 28348207 Free PMC article.
Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice.
Argyrofthalmidou M, Spathis AD, Maniati M, Poula A, Katsianou MA, Sotiriou E, Manousaki M, Perier C, Papapanagiotou I, Papadopoulou-Daifoti Z, Pitychoutis PM, Alexakos P, Vila M, Stefanis L, Vassilatis DK. Argyrofthalmidou M, et al. Among authors: vassilatis dk. Hum Mol Genet. 2021 Jul 28;30(16):1469-1483. doi: 10.1093/hmg/ddab118. Hum Mol Genet. 2021. PMID: 33902111 Free PMC article.
Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons.
Argyrofthalmidou M, Polissidis A, Karaliota S, Papapanagiotou I, Sotiriou E, Manousaki M, Papadopoulou-Daifoti Z, Spillantini MG, Stefanis L, Vassilatis DK. Argyrofthalmidou M, et al. Among authors: vassilatis dk. Neuroscience. 2022 Dec 1;506:114-126. doi: 10.1016/j.neuroscience.2022.10.011. Epub 2022 Oct 19. Neuroscience. 2022. PMID: 36270413
Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease.
Angelopoulou E, Bozi M, Simitsi AM, Koros C, Antonelou R, Papagiannakis N, Maniati M, Poula D, Stamelou M, Vassilatis DK, Michalopoulos I, Geronikolou S, Scarmeas N, Stefanis L. Angelopoulou E, et al. Among authors: vassilatis dk. J Neurol Sci. 2022 Nov 15;442:120405. doi: 10.1016/j.jns.2022.120405. Epub 2022 Sep 2. J Neurol Sci. 2022. PMID: 36081304
Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.
Bozi M, Papadimitriou D, Antonellou R, Moraitou M, Maniati M, Vassilatis DK, Papageorgiou SG, Leonardos A, Tagaris G, Malamis G, Theofilopoulos D, Kamakari S, Stamboulis E, Hadjigeorgiou GM, Athanassiadou A, Michelakakis H, Papadimitriou A, Gasser T, Stefanis L. Bozi M, et al. Among authors: vassilatis dk. Eur J Neurol. 2014 Jul;21(7):963-8. doi: 10.1111/ene.12315. Epub 2013 Dec 7. Eur J Neurol. 2014. PMID: 24313877
The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.
Angelopoulou E, Bozi M, Simitsi AM, Koros C, Antonelou R, Papagiannakis N, Maniati M, Poula D, Stamelou M, Vassilatis DK, Michalopoulos I, Geronikolou S, Scarmeas N, Stefanis L. Angelopoulou E, et al. Among authors: vassilatis dk. Parkinsonism Relat Disord. 2019 Oct;67:105-112. doi: 10.1016/j.parkreldis.2019.08.013. Epub 2019 Aug 26. Parkinsonism Relat Disord. 2019. PMID: 31494049
Mutations in NR4A2 associated with familial Parkinson disease.
Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. Le WD, et al. Among authors: vassilatis dk. Nat Genet. 2003 Jan;33(1):85-9. doi: 10.1038/ng1066. Epub 2002 Dec 23. Nat Genet. 2003. PMID: 12496759
32 results